NeoVista Company
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 million people around the world and is a major cause of blindness in men and women over the age of 50. The unique technology being developed by NeoVista continues to show promise in clinical studies. It is our goal to help improve the quality of care and reduce the burden of this destructive condition on patients, physicians, and the healthcare system.
Investors
Last Funding Type:
Post-IPO Equity
Headquarters:
Newark, California, United States
Founded Date:
1-1
Investor Type:
For Profit
Total Funding:
$20M
Technology:
P4 Medicine
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investors Number:
3
Industry:
Health Care, Health Diagnostics, Medical Device